CD4+CD25+ regulatory T cells-derived exosomes prolonged kidney allograft survival in a rat model.

[1]  R. Lechler,et al.  Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action. , 2009, International immunopharmacology.

[2]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[3]  R. González-Amaro,et al.  Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level. , 2009, Transplant immunology.

[4]  B. Shi,et al.  Low-dose of tacrolimus favors the induction of functional CD4(+)CD25(+)FoxP3(+) regulatory T cells in solid-organ transplantation. , 2009, International immunopharmacology.

[5]  C. Kim,et al.  MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. , 2009, Cancer letters.

[6]  E. Telemo,et al.  Serum‐derived exosomes from antigen‐fed mice prevent allergic sensitization in a model of allergic asthma , 2008, Immunology.

[7]  B. Shi,et al.  Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation. , 2008, Transplant immunology.

[8]  M. Eisenacher,et al.  Activation of counter-regulatory mechanisms in a rat renal acute rejection model , 2008, BMC Genomics.

[9]  S. Gabrielsson,et al.  B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. , 2007, The Journal of allergy and clinical immunology.

[10]  H. Koenen,et al.  Ex vivo expansion of human CD4+ CD25high regulatory T cells from transplant recipients permits functional analysis of small blood samples. , 2006, Journal of immunological methods.

[11]  W. Grizzle,et al.  A Membrane Form of TNF-α Presented by Exosomes Delays T Cell Activation-Induced Cell Death1 , 2006, The Journal of Immunology.

[12]  R. Johnstone,et al.  Exosomes biological significance: A concise review. , 2006, Blood cells, molecules & diseases.

[13]  Olivier Lantz,et al.  Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial , 2005, Journal of Translational Medicine.

[14]  L. Zitvogel,et al.  Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection 1 , 2004, The Journal of Immunology.

[15]  L. Zitvogel,et al.  Exosome-based immunotherapy , 2004, Cancer Immunology, Immunotherapy.

[16]  C. Usal,et al.  Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection1 , 2003, Transplantation.

[17]  C. Fathman,et al.  Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation , 2002, The Journal of experimental medicine.

[18]  H. Weiner,et al.  Activation of CD25+CD4+ Regulatory T Cells by Oral Antigen Administration1 , 2001, The Journal of Immunology.

[19]  H. Weiner.  Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. , 2001, Microbes and infection.

[20]  M. Hammerman.  Transplantation of renal precursor cells: a new therapeutic approach , 2000, Pediatric Nephrology.

[21]  C. Weber,et al.  Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  J. Xiang,et al.  CD4+ T cell-released exosomes inhibit CD8+ cytotoxic T-lymphocyte responses and antitumor immunity , 2011, Cellular and Molecular Immunology.

[23]  Sheng-fu Li,et al.  Open Access Research Article Peripheral Blood T Regulatory Cell Counts May Not Predict Transplant Rejection , 2022 .